Response to Toi et al. (doi: 10.1089/neu.2018.5821): Determining if Cerebrospinal Fluid Prevent Recurrence of Chronic Subdural Hematoma: A Multi-Center Prospective Randomized Clinical Trial
Response to Toi et al. (doi: 10.1089/neu.2018.5821): Determining if Cerebrospinal Fluid Prevent Recurrence of Chronic Subdural Hematoma: A Multi-Center Prospective Randomized Clinical Trial
复制标题
对 Toi 等人的回应
DOI：
10.1089/neu.2018.6032
复制
发表时间：
2018
影响因子：
4.2
通讯作者：
Yoshinori Higuchi
中科院分区：
文献类型：
--
作者：
Akihiko Adachi;Yoshinori Higuchi
尽管存在上述未被认识到的局限性，Toi及其同事克服了设计和实施随机对照试验的困难，似乎最终结束了CSDH治疗中有争议的话题。
ConclusionDespite the aforementioned unrecognized limitation, Toi and colleagues overcame the difficulty of designing and conducting a randomized controlled trial, and seem to have finally put an end to a controversial topic in CSDH treatment.